AxoGen Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
10,947.40
16,817.40
27,331.10
41,107.50
60,426.40
83,937
Cost of Goods Sold (COGS) incl. D&A
2,439.80
3,442.20
4,848.40
6,467.30
9,311.60
12,923
Gross Income
8,507.50
13,375.20
22,482.70
34,640.30
51,114.80
71,014
SG&A Expense
18,099.70
23,176.00
31,749.40
42,770.20
59,066.10
91,514
EBIT
9,592.20
9,800.80
-
8,129.90
7,951.30
20,500
Unusual Expense
9.40
-
-
750.00
-
2,186
Non Operating Income/Expense
43.30
3.20
26.80
19.60
30.80
28
Interest Expense
4,998.60
7,912.80
4,116.50
5,511.70
2,463.40
1,208
Pretax Income
14,556.90
17,710.50
13,356.40
14,411.10
10,445.50
22,397
Consolidated Net Income
14,556.90
17,710.50
13,356.40
14,411.10
10,445.50
22,397
Net Income
14,556.90
17,710.50
13,356.40
14,411.10
10,445.50
22,397
Net Income After Extraordinaries
14,556.90
17,710.50
13,356.40
14,411.10
10,445.50
22,397
Net Income Available to Common
14,556.90
17,710.50
13,356.40
14,411.10
10,445.50
22,397
EPS (Basic)
1.08
1.00
0.51
0.47
0.31
0.60
Basic Shares Outstanding
13,499.80
17,721.70
26,075.70
30,702.20
33,322.80
37,127
EPS (Diluted)
1.08
1.00
0.51
0.47
0.31
0.60
Diluted Shares Outstanding
13,499.80
17,721.70
26,075.70
30,702.20
33,322.80
37,127
EBITDA
9,453.90
9,601.90
9,017.70
7,693.40
7,384.70
19,649

About AxoGen

View Profile
Address
13631 Progress Boulevard
Alachua Florida 32615
United States
Employees -
Website http://www.axogeninc.com
Updated 07/08/2019
AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provide products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator.